investors | ptc therapeutics, inc.
the investor relations website contains information about ptc therapeutics, inc.'s business for stockholders, potential investors, and financial analysts.
Total Visits
Avg. Visit Duration
Pages per Visit
Bounce Rate
Registration Date
| Month | Traffic |
|---|---|
| 2025-02 | 6.087 |
| 2025-03 | 4.251 |
| 2025-04 | 2.969 |
| Source | Traffic Share |
|---|---|
| search | 44.00% |
| direct | 41.85% |
| referrals | 7.14% |
| social | 5.80% |
| paid referrals | 1.09% |
| 0.08% |
| Region | Percentage |
|---|---|
| United States | 61.65% |
| India | 15.45% |
| Japan | 11.51% |
| IT | 6.28% |
| TR | 5.11% |
| Keyword | Traffic | Volume | CPC |
|---|---|---|---|
| ptcbio.com rna targeted therapeutics | 2 | 20 | $0.00 |
| vatiquinone | 54 | 540 | $0.00 |
| ptc therapeutics | 722 | 7,220 | $3.78 |
| 15 lo pathway" ptc | 0 | 0 | $0.00 |
| huntington's phase 3 | 0 | 0 | $0.00 |